NCT01924806

A Pilot Study of the WoundWand™ Debridement Device on Infection Prevention

• Status: Terminated
• Phase: N/A
• Study type: Interventional
• Enrollment: 11 (actual)
• Sponsor: Smith & Nephew, Inc. · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

A Pilot Study of the WoundWand™ Debridement Device on Infection Prevention

Detailed description

The primary aim of this pilot study is to investigate differences in bacterial content of the study wound that may impact upon infection rates following debridement with the WoundWand Debridement Device or Standard of Care (SoC) surgical (sharp) debridement. Additionally, the clinical investigation will evaluate reduction in wound size post-debridement and gather Health Economic data relating to wound bed debridement with the WoundWand Debridement Device or SoC.

Conditions

• Lower Leg Wound

Interventions

Type	Name	Description
DEVICE	WoundWand™ Debridement Device	Group I - Electrical energy that removes necrotic, ischemic, and/or infected tissue within a wound
DEVICE	Standard of Care sharp debridement	Group II - Sharp instruments that remove necrotic, ischemic, and/or infected tissue within a wound

Timeline

• Start date: 2014-03-04
• Primary completion: 2015-02-09
• Completion: 2015-02-09
• First posted: 2013-08-19
• Last updated: 2020-02-28
• Results posted: 2020-02-28

Locations

2 sites across 2 countries: France, United Kingdom